Speech-Language Pathologists in Somerset, WI Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Christine Milde-rothe, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 210 Acorn Lane, Somerset, WI 54025 Phone: 715-531-8707 |
Katelyn Mary Kippes Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Main St, Somerset, WI 54025 Phone: 715-690-7326 |
Mrs. Terri Marie Satersmoen, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1711 41st St, Somerset, WI 54025 Phone: 651-274-5453 |
News Archive
Three Rivers Pharmaceuticals receives FDA expanded labeling for INFERGEN
Three Rivers Pharmaceuticals, LLC, today received expanded labeling from the U.S. Food and Drug Administration (FDA) to include daily use of INFERGEN (Consensus Interferon) in combination with ribavirin (RBV) for retreatment of chronic hepatitis C patients. The expanded labeling targets hepatitis C patients who need retreatment.
Novel clinical research approaches for rapidly identifying and preventing congenital cardiovascular defects
Structural and functional congenital cardiovascular abnormalities present at birth are the leading source of all congenital defects encountered in live births. Nearly half a million children in the United States have structural heart problems ranging in severity from relatively simple issues, such as small holes between chambers of the heart, to very severe malformations, including complete absence of one or more chambers or valves.
Advanced Cell Technology first quarter net loss decreases to $3.3 million
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.
Researchers identify three novel genetic mutations linked to Fuchs dystrophy
Researchers discovered three novel genetic mutations associated with Fuchs endothelial corneal dystrophy, the most common corneal disorder requiring transplantation.
› Verified 7 days ago